CSI Market
Sign In | Register

Amphastar Pharmaceuticals Inc (AMPH) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AMPH quarterly Cash Flow →
The quarterly cash flow data below helps track how Amphastar Pharmaceuticals Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income98.09
Depreciation & amortization31.65
Amortization of Other Assets28.40
Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-21.06
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.04
Share-based Compensation27.28
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Sharebased Compensation Expense Nonemployee-
Increase Decrease In Income Tax Refund Deposits And Payable-24.84
Deconsolidation Gain Or Loss Amount-
Operating Lease Right Of Use Asset Amortization Expense6.51
Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments-1.03
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-6.37
Increase (Decrease) in Accounts Payable and Accrued Liabilities-4.56
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets25.13
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-3.12
Discontinued operations0.00
Net Cash flow from Operating Activities156.12
Investing Activities
Capital Expenditures-37.13
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities90.29
Payments to Acquire Marketable Securities-119.13
Real Estate Investments0.00
Capitalizedlabor O H and I N T E R E S T Expenditures Incurred But Not Yet Paid-
Payments For Deposits And Other Assets-4.36
Capitalized Labor Overhead And Interest On Self Constructed Assets-
Purchase Of Short Term Investments-
Payments Acquisitions Of Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-70.33
Financing Activities
Short-term debt Net6.22
Other borrowing transactions-0.69
Long-term debt - borrowings0.00
Long-term debt - repayments-0.22
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-72.73
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments Of Deferred Issuance Costs-
Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net Of Withholding Tax Payments-
Acquisition Of Additional Ownership Interest In Anp-
Settlement Of Equity Awards-
Payments To Acquire Additional Ownership Interest-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-67.43
Effect of exchange rate on cash flow0.21
Discontinued operations0.00
Free Cash Flow118.98
Total Cash Flow18.57
4 historic quarters locked

Sign in to unlock the full Amphastar Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Amphastar Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001297184-26-000009

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License